Global Stem Cell Reconstructive Market- Global Industry Forecast to 2023

Global stem cell reconstructive market - Overview

Stem cell reconstructive surgery involves the treatment of injured or damaged part of body. Stem cells are undifferentiated biological cells which can divide to produce more stem cells. The major factors contributing to the market growth includes increasing number of geriatric population, rising number of patients suffering from chronic diseases and continuous development in the technology. Furthermore, increasing need for the alternative treatments for the diseases, government support for the development of the new products and increasing healthcare expenditure has fuelled the growth of market. According to International Diabetes Federation, in 2016, it was estimated that 420 million adult population was suffering from diabetes worldwide.

These cells are unspecialized and capable of perpetuating itself through cell division. It can give rise to differentiated cells with specialized functions. Stem cells are used in the treatment of various diseases such as cancer, diabetes and others. According to American Diabetic Association, in 2012 about 29 million Americans were suffering from diabetes, this increasing patient population in this region and continuously developing technology has stimulated the growth of this market in America.

This rising patient population has simultaneously increase the demand for the new treatment and thus driven the growth of the market. However, high cost of the treatment may hinder the growth of the market.

Industry Updates

May, 2016 NuVasive launched the next generation synthetic bone graft product namely AttraX Putty in U.S. This initiative has expanded the NuVasive’s biologics product portfolio.

July, 2014 Takara Bio Inc. entered into an agreement to acquire Cellectis SA, a stem cell business firm. This acquisition expanded Takara’s stem cell product portfolio in the field of regenerative medicines.

Global Stem cell reconstructive market - Regional Analysis

Global Stem Cell Market Analysis Fact Sheet, on the basis of regions is divided into Americas, Europe, Asia Pacific and Middle East and Africa.

America accounts for the largest and the fastest growing market of stem cell reconstructive owing to large patient population and well developed healthcare sector. America stem cell reconstructive market is segmented into two major regions: North America and South America. More than 80% of the market is shared by North America owing to the presence of US and Canada. According to the National Cancer Institute (2016), around 1,685,210 new cases of cancer have been diagnosed in the United States. According to World Health Organization (WHO), 9.3% of American population is suffering from diabetes. This increasing prevalence of cancer and diabetes in America is the major driving factor for the growth of this market. Moreover, government support for research and development, well developed technology and high healthcare expenditure has fuelled the growth of the market.

Europe accounts for the second largest market which is followed by Asia Pacific. Germany and UK accounts the major share in the Europe market owing to well developed technology and healthcare sector

Asia Pacific has the developing market for stem cell reconstructive. Japan and Australia are the major contributor for the market in Asia Pacific. The global market for stem cell reconstruction has expanded rapidly with new suppliers particularly in emerging economies such as India, China and Singapore. Available treatments span the full range of medical services but most commonly include dental care, cosmetic surgery, and fertility treatment.

Middle East and Africa contribute least in the global stem cell reconstructive market.

Global Stem cell reconstructive market - Company Analysis

The stem cell reconstructive market has huge opportunities. The prominent players in the market adopt various strategies such as product launches, product innovation, and R&D investment to increase their market. Moreover, tier 1 companies employ strategies like merger, and acquisition of the competition as their developmental strategies to sustain in the market.

In Feb 2012, Baxter initiated phase III adult stem cell clinical trial for chronic cardiac condition. A company is focusing of the development of the new products and investing a huge amount of capital in research and development.

Baxter (US), Cytori Therapeutics Inc. (U.S), Eleveflow (France), Mesoblast Ltd. (Australia), NuVasive Inc. (US), Osiris (US), Micronit Microfluidics (Netherlands), Takara Bio Inc.(Japan), Tigenix (Belgium), Cynata (Australia), Celyad (Belgium), Capricor Therapeutics (Canada), Astellas Pharma US, Inc. (US), Pfizer Inc. (US), StemCells Inc (US), STEMCELL Technologies Inc. (US), Caladrius (US) and others are some of the prominent players at the forefront of competition in the global stem cell reconstructive market and are profiled in MRFR Analysis. 

Report Details @ https://www.marketresearchfuture.com/reports/stem-cell-reconstructive-market-993

Stem Cell Reconstructive Market to Expand at a Robust CAGR of 22.6% Between 2017 and 2023

/MRFR Press Release/- Market Research Future has published a half-cooked research report on the Global Stem Cell Reconstructive Market.

Stem cell reconstructive is a procedure involving the usages of a patient’s own adipose tissue to increase the fat volume in the area of reconstruction and thus promoting 3Dimentional reconstruction in patients who have undergone a trauma or in a post-surgical event such as a mastectomy or lumpectomy, brain surgery, or who need the reconstructive surgery as a result of an accident or injury. Stem cell reconstructive surgeries are also used in cosmetic or plastic surgeries.

Over the past few years, increasing reconstructive surgeries led by the increasing number of accidents, limbs amputation and implants are fostering the growth in the stem cell reconstructive market. Besides, the factors such as increasing geriatric populations, rising number of patients suffering from chronic diseases, and continuous development in the technology are escalating the market on the global level.

Acknowledging the kind of growth this market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the booming, global stem cell reconstructive market will register a whopping double digit CAGR of 22.6% during the forecast period 2017-2023.

Growing demand for fat & skin grafting procedures is a key driving force behind the market growth. Moreover, the growing prevalence of obesity is fostering the market growth of stem cell reconstructive, driving the plastic surgery & integumentary system market.

Growing demand for facial aesthetic treatments, technological advancements in the plastic surgery industry, high demand for the plastic surgery & integumentary system application such as facelift procedures is some of the significant factors that are driving the market growth of stem cell reconstructive surgeries. Additionally, the growing prevalence of skin diseases and increased activities in research laboratories, pharmaceutical and dermatology companies are fostering the market growth further.

On the other hand, factors such as high cost of stem cell reconstructive surgeries and stringent regulatory approvals are acting as a headwind obstructing the market growth. Besides, high risks of adverse effects associated with these surgeries can also impede the market growth. Nevertheless, factors such as the increasing need for alternative treatments, government support for the development of new products, and rising healthcare expenditure are expected to support the market growth over the assessment period. 

Stem Cell Reconstructive Market - Segments

MRFR has segmented its analysis into five key dynamics for the convenience of understanding;

By Sources: Allogeneic, Autologous (bone marrow, adipose tissue, and blood.), and Syngeneic among other.

By Cell Types: Embryonic Stem Cell and Adult Stem Cell among others.

By Applications: Cancer, Diabetes, Traumatic Skin Defect, and Severe Burn among others.

By End-Users: Hospital and Research Institutes among others.

By Regions:  Europe, North America, APAC and the Rest-of-the-World (RoW). 

Stem Cell Reconstructive Market - Regional Analysis

Globally North America market dominates the stem cell reconstructive market with the largest share. Factors such as the notable increase in incidences of stem cell reconstructive surgeries and encouraging research and development in healthcare drive the market growth in the region. Additional factors such as the increasing uptake of advanced technologies and high healthcare expenditures are substantiating the market growth.

Owing to the rising demands for stem cell reconstructive procedures, this market is expected to create a larger revenue pocket globally, by 2023. The US among other North American countries, backed by the high expenditure on healthcare coupled with the increasing demand for stem cell reconstructive treatments, accounts for the major contributor to the market growth.

The European accounts for the second largest market for stem cell reconstructive, globally, attributing to the recent advancements in the medical technology and the augmenting these techniques in the region.  Additionally, the presence of a substantial patient population alongside the rising healthcare expenditure facilitates the growth of the regional market. Besides, public & private sectors' support and funding for research & development are expected to fuel the market growth in the region over the review period.

The Asia Pacific region is rapidly emerging as a lucrative market for stem cell reconstructive due to the increasing incidents of these surgeries and the development of related technologies mainly in the countries such as India, China, and Japan. The APAC market backed by the rising demand for these procedures and increasing adoption of the technologies is projected to register a phenomenal CAGR during the forecast period.

Global Stem Cell Reconstructive Market - Competitive Analysis

The fiercely competitive stem cell reconstructive market appears fragmented due to the presence of many well-established as well as small & new entrants. Innovation/ new technology launch remain the popular trends among the key market players. The growth statistics of the market presage the probable heights the market can reach further.

Access Report Details @ https://www.marketresearchfuture.com/reports/stem-cell-reconstructive-market-993

Key Players:

The global stem cell reconstructive market is led by some of the fervent players including Cytori Therapeutics Inc. (U.S), Baxter (US), Eleveflow (France), NuVasive Inc. (US), Mesoblast Ltd. (Australia), Osiris Therapeutics, Inc.  (US), TAKARA BIO INC.(Japan), Micronit Microfluidics (Netherlands), Tigenix (Belgium), Celyad (Belgium), Cynata (Australia), Capricor Therapeutics (Canada), Pfizer Inc. (US), Astellas Pharma US, Inc. (US), StemCells Inc (US), Caladrius (US), and STEMCELL Technologies Inc. (US).

Industry/Innovations/Related News:

October 2, 2018 – A team of doctors at the Wolters Kluwer Health (US) published their study of a new technique of repairing cleft palate in infants that they have developed in The Journal of Craniofacial Surgery. These doctors say that it could be a promising new approach to repair of cleft palate in infants. The technique developed in a study led by Dr. Botero, involves usages of umbilical cord blood stem cells.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com